PL418295A1 - Granulated material that contains butyrate compound, method for obtaining it and applications - Google Patents

Granulated material that contains butyrate compound, method for obtaining it and applications

Info

Publication number
PL418295A1
PL418295A1 PL418295A PL41829516A PL418295A1 PL 418295 A1 PL418295 A1 PL 418295A1 PL 418295 A PL418295 A PL 418295A PL 41829516 A PL41829516 A PL 41829516A PL 418295 A1 PL418295 A1 PL 418295A1
Authority
PL
Poland
Prior art keywords
obtaining
applications
granulated material
butyrate compound
subject
Prior art date
Application number
PL418295A
Other languages
Polish (pl)
Other versions
PL233287B1 (en
Inventor
Michał Łuczyński
Original Assignee
Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna
Łuczyński Michał Chemprof Doradztwo Chemiczne Spółka Cywilna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna, Łuczyński Michał Chemprof Doradztwo Chemiczne Spółka Cywilna filed Critical Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna
Priority to PL418295A priority Critical patent/PL233287B1/en
Publication of PL418295A1 publication Critical patent/PL418295A1/en
Publication of PL233287B1 publication Critical patent/PL233287B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest granulat zawierający od 45 do 85% wag. związku maślanu, korzystnie maślanu sodu, w matrycy acyloglicerolowej, zawierającej acyloglicerole w określonej proporcji. Przedmiotem zgłoszenia jest także sposób wytwarzania i zastosowanie granulatu w zapobieganiu chorobom i/lub leczeniu chorób jelit o podłożu zapalnym lub jako żywności specjalnego przeznaczenia medycznego.The subject of the application is a granulate containing from 45 to 85 wt. butyrate compound, preferably sodium butyrate, in an acylglycerol matrix, containing acylglycerols in a certain proportion. The subject of the application is also a method for the production and use of granules in the prevention of and / or the treatment of inflammatory bowel diseases or as food for special medical purposes.

PL418295A 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications PL233287B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Publications (2)

Publication Number Publication Date
PL418295A1 true PL418295A1 (en) 2018-02-12
PL233287B1 PL233287B1 (en) 2019-09-30

Family

ID=61148664

Family Applications (1)

Application Number Title Priority Date Filing Date
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Country Status (1)

Country Link
PL (1) PL233287B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL446457A1 (en) * 2023-10-22 2025-04-28 Probiome Spółka Z Ograniczoną Odpowiedzialnością Granules containing a butyrate compound, a unit dosage form containing it and its new use
PL447248A1 (en) * 2023-12-22 2025-06-23 Probiome Spółka Z Ograniczoną Odpowiedzialnością Granulate containing sodium butyrate compound, its forms and applications

Also Published As

Publication number Publication date
PL233287B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
McClave et al. Summary points and consensus recommendations from the North American Surgical Nutrition Summit
MX391850B (en) COMPOUNDS FOR USE IN THE TREATMENT OR AMENDING OF HUNTINGTON'S DISEASE
JOP20170105B1 (en) Amide-substituted pyridinyltriazole derivatives and their use
MX2016005668A (en) Crystalline forms of therapeutic compounds and uses thereof.
PH12017501669A1 (en) Alpha-cinnamide compounds and compositions as hdac8 inhibitors
MY201921A (en) Agent for preventing or treating fat-associated diseases and/or inflammation
PH12021551455A1 (en) Jak1 pathway inhibitors for the treatment of gastrointestinal disease
MY177906A (en) Composition and method for aiding sleep
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
MX384068B (en) Composition comprising mannose oligosaccharide and process for making same and use thereof
MY190687A (en) Antimicrobial compositions and related methods of use
MX2019001634A (en) AMIDAS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THESE AND METHODS TO USE THEM.
MX2021013354A (en) Methods of treating and/or preventing actinic keratosis.
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
CL2018001017A1 (en) Conservation of water-soluble vitamins.
HK1257296A1 (en) New compounds and their uses
BR112017020968A2 (en) A water depurator and a water cleaning method
BR112017010621A2 (en) fire resistant calcium sulphate products
MX2022015456A (en) Maca compositions and methods of use.
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
MX2018000092A (en) New bicyclic lipolantipeptide, preparation and use as antimicrobial agent.
BR112017020971A2 (en) A water depurator and a water cleaning method
JP2017014164A5 (en)
MX2016006265A (en) Improved gelatine composition.
PH12020550444A1 (en) Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals